Exercise training reduces liver fat, lowers blood sugar and insulin, and improves mitochondrial function in people with nonalcoholic fatty liver disease.
Read the full answer →
Yes, exercise training reduces liver fat in people with NAFLD, with high-intensity interval training and aerobic exercise showing the strongest effects.
Read the full answer →
Current management for nonalcoholic fatty liver disease focuses on lifestyle changes like weight loss and exercise, while new drug options are being studied but none are yet approved in the United States.
Read the full answer →
Eating ultra-processed foods is linked to obesity and metabolic disease, which are major drivers of nonalcoholic fatty liver disease (NAFLD).
Read the full answer →
Lifestyle changes (diet, exercise, weight loss) are the mainstay of NAFLD/NASH management; vitamin E and some medications may help, but always consult your doctor.
Read the full answer →
Recent reviews link NAFLD to periodontitis, type 2 diabetes, obesity, cardiovascular disease, and bile acid-related conditions like IBS-D and CRC.
Read the full answer →
A pilot study suggests ketotifen may improve liver fat and fibrosis more than vitamin E in NAFLD, but more research is needed.
Read the full answer →
Single-cell RNA sequencing helps researchers study NAFLD by revealing which liver cell types drive disease progression and identifying new biomarkers for diagnosis.
Read the full answer →
Yes, elevated testosterone levels, especially free and bioavailable testosterone, are linked to a higher risk of NAFLD, particularly in postmenopausal women and women with PCOS.
Read the full answer →